Teva must pay $235m to GSK for patent infringement
22-06-2017
AVNphotolab / iStockphoto.com
A US judge has overturned a jury verdict which found that Teva owed GSK $235 million in damages for infringing a patent covering a blood pressure drug.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, GSK, generics, jury, Coreg, heart medication, patent infringement, damages,
